HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic.

Abstract
In this longitudinal cohort study, we assessed the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) seroconversion rates and analyzed the coronavirus disease 2019 (COVID-19) vaccine-induced immunity of 872 hospital workers at the University Medical Center Hamburg-Eppendorf between May 11 and May 31, 2021. The overall seroprevalence of anti-NC-SARS-CoV-2 antibodies was 4.7% (n = 41), indicating low SARS-CoV-2 infection rates and persistent effectiveness of hospital-wide infection control interventions during the second and third wave of the pandemic. In total, 92.7% (n = 808) out of the entire study cohort, 98.2% (n = 325) of those who had been vaccinated once and all 393 individuals who had been vaccinated twice had detectable anti-S1-RBD-SARS-CoV-2 antibody titers and no significant differences in vaccine-induced immune response were detected between male and female individuals and between different age groups. Vaccinated study participants with detectable anti-NC-SARS-CoV-2 antibody titers (n = 30) developed generally higher anti-S1-RBD-SARS-CoV-2 antibody titers compared to anti-NC-SARS-CoV-2 negative individuals (n = 694) (median titer: 7812 vs. 345 BAU/ml, p < 0.0001). Furthermore, study participants who received heterologous vaccination with AZD1222 followed by an mRNA vaccine showed markedly higher anti-S1-RBD-SARS-CoV-2 antibody titers than individuals who received two doses of an mRNA vaccine or two doses of AZD1222 (median titer: AZD1222/AZD1222: 1069 BAU/ml, mRNA/mRNA: 1388 BAU/ml, AZD1222/mRNA: 9450 BAU/ml; p < 0.0001). Our results indicate that infection control interventions were generally effective in preventing nosocomial transmission of SARS-CoV-2 and that COVID-19 vaccines can elicit strong humoral responses in the majority of a real-world cohort of hospital workers.
AuthorsThomas Theo Brehm, Michelle Thompson, Felix Ullrich, Dorothee Schwinge, Marylyn M Addo, Anthea Spier, Johannes K Knobloch, Martin Aepfelbacher, Ansgar W Lohse, Marc Lütgehetmann, Julian Schulze Zur Wiesch
JournalInternational journal of hygiene and environmental health (Int J Hyg Environ Health) Vol. 238 Pg. 113851 (09 2021) ISSN: 1618-131X [Electronic] Germany
PMID34601375 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Elsevier GmbH. All rights reserved.
Chemical References
  • Antibodies, Viral
  • COVID-19 Vaccines
  • Vaccines
  • ChAdOx1 nCoV-19
Topics
  • Antibodies, Viral
  • COVID-19
  • COVID-19 Vaccines
  • ChAdOx1 nCoV-19
  • Female
  • Health Personnel
  • Humans
  • Longitudinal Studies
  • Male
  • Pandemics
  • SARS-CoV-2
  • Seroepidemiologic Studies
  • Vaccines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: